Arjo AB (FRA:A39) PEG Ratio: N/A (As of Jul. 06, 2026)


FRA:A39 Arjo AB FRA:A39
74 GF Score
Price €2.37
GF Value €3.21
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Arjo AB PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Arjo AB's PE Ratio without NRI is 16.15. Arjo AB's 5-Year EBITDA growth rate is -0.10%. Therefore, Arjo AB's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Arjo AB's PEG Ratio or its related term are showing as below:


During the past 13 years, Arjo AB's highest PEG Ratio was 9.33. The lowest was 0.91. And the median was 4.19.


FRA:A39's PEG Ratio is not ranked *
in the Medical Distribution industry.
Industry Median: 1.895
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Arjo AB  (FRA:A39) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Arjo AB PEG Ratio Related Terms


Arjo AB PEG Ratio Historical Data

* Premium members only.

The historical data trend for Arjo AB's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arjo AB PEG Ratio Chart

Arjo AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.13 1.11 3.25 6.20 8.45

Arjo AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.85 6.96 6.69 8.45 8.56

FRA:A39 vs MCK, CAH, COR: PEG Ratio Comparison

For the Medical Distribution subindustry, Arjo AB's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arjo AB PEG Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Arjo AB's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Arjo AB's PEG Ratio falls into.


FRA:A39
74GF Score
Arjo AB FRA:A39
PEG Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arjo AB PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Arjo AB's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=16.149659863946/-0.10
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.

Is Arjo AB (FRA:A39) Overvalued in 2026?

Based on GuruFocus' analysis, Arjo AB stock appears to be undervalued. The current stock price of €2.37 is trading 26% below its estimated GF Value™ of €3.21. GuruFocus considers Arjo AB to be Modestly Undervalued.

Key valuation signals for FRA:A39:

  • PEG Ratio: N/A
  • GF Value™: €3.21 vs. price of €2.37 (26% below fair value)
  • GF Score™: 74/100 with 5 warning signs

No single metric tells the full story. See the FRA:A39 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Arjo AB Business Description

Address Hans Michelsensgatan 10, Box 48, Malmo, SWE, SE-201 20
Arjo AB is a supplier of medical devices, services, and solutions in Sweden. It serves its services to private and public institutions with acute care and long-term care. The company's offering includes products and solutions for patient handling, hygiene, disinfection, medical beds, therapeutic surfaces, venous thromboembolism (VTE) prevention and diagnostics. The company includes segments: Global Sales, North America, Diagnostics.
74GF Score

Get the complete analysis for FRA:A39

PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.37
Price
€3.21
GF Value